Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131.5 USD | +0.62% | -2.26% | +5.99% |
Apr. 16 | Dexcom Insider Sold Shares Worth $274,242, According to a Recent SEC Filing | MT |
Apr. 15 | BTIG Adjusts DexCom's Price Target to $156 From $150 | MT |
Financials (USD)
Sales 2024 * | 4.33B | Sales 2025 * | 5.15B | Capitalization | 50.7B |
---|---|---|---|---|---|
Net income 2024 * | 679M | Net income 2025 * | 888M | EV / Sales 2024 * | 12.1 x |
Net Debt 2024 * | 1.51B | Net Debt 2025 * | 978M | EV / Sales 2025 * | 10 x |
P/E ratio 2024 * |
78.3
x | P/E ratio 2025 * |
60.9
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.27% |
Latest transcript on DexCom, Inc.
1 day | +0.62% | ||
1 week | -2.26% | ||
Current month | -5.18% | ||
1 month | -1.25% | ||
3 months | +1.72% | ||
6 months | +52.98% | ||
Current year | +5.99% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 07-10-31 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Chief Tech/Sci/R&D Officer | 47 | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 09-11-19 |
Mark Foletta
BRD | Director/Board Member | 63 | 14-11-18 |
Eric Topol
BRD | Director/Board Member | 69 | 09-07-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.46% | 18 M€ | +2.56% | - | |
1.04% | 16 M€ | -7.93% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 131.5 | +0.62% | 2,110,326 |
24-04-19 | 130.7 | -2.67% | 2,859,646 |
24-04-18 | 134.3 | +0.33% | 2,116,531 |
24-04-17 | 133.9 | -1.95% | 3,222,471 |
24-04-16 | 136.5 | +1.46% | 3,036,409 |
Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.99% | 50.7B | |
-2.73% | 186B | |
-2.20% | 107B | |
-4.08% | 67.57B | |
+15.32% | 47.2B | |
-0.45% | 39.72B | |
+6.60% | 27.48B | |
-1.11% | 25.65B | |
-0.76% | 24.82B | |
+13.37% | 24.97B |
- Stock Market
- Equities
- DXCM Stock